[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100434814":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":30,"responsibleParty":171,"collaborators":173,"id":177,"slug":11,"hasResults":178,"nctId":179,"briefTitle":180,"officialTitle":180,"acronym":181,"eligibilityCriteria":182,"healthyVolunteers":178,"sex":183,"minAge":184,"maxAge":11,"enrollmentInfo":185,"targetDuration":11,"studyType":188,"phases":189,"briefSummary":191,"conditions":192,"keywords":197,"overallStatus":33,"whyStopped":11,"lastUpdateSubmitDate":201,"lastUpdatePostDateStruct":202,"startDateStruct":205,"completionDateStruct":207,"leadSponsor":209,"locationsCount":210},{"fullName":5,"class":6},"University Hospital, Angers","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"CALRSUIVI cohort","EXPERIMENTAL",null,[13],"Biological: CALR allele burden quantification",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"BIOLOGICAL","CALR allele burden quantification","* DNA extraction from blood sample for CALR mutation quantification (fragment analysis)\n* at diagnosis and follow-up (inclusion period: 3 years)\n* max 1 sample\u002Fyear\n* secondary outcome: mutational landscape by Next Generation Sequencing (NGS) analysis at diagnosis",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Laurane COTTIN, Doctor","CONTACT","+33 2 41 35 53 53","Laurane.Cottin@chu-angers.fr",{"name":27,"role":23,"phone":28,"phoneExt":11,"email":29},"Emma BLANCHET","+33 2 41 35 63 38","EmBlanchet@chu-angers.fr",[31,45,59,73,87,101,115,129,143,157],{"facility":32,"status":33,"city":34,"state":11,"zip":11,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"CHU Angers","RECRUITING","Angers","France",{"type":37,"coordinates":38},"Point",[39,40],-0.55202,47.47156,{"lat":40,"lon":39},[43],{"name":44,"role":23,"phone":11,"phoneExt":11,"email":11},"Laurane COTTIN, Dr",{"facility":46,"status":33,"city":47,"state":11,"zip":48,"country":35,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"Chu Bordeaux","Bordeaux","33604",{"type":37,"coordinates":50},[51,52],-0.58046,44.84124,{"lat":52,"lon":51},[55],{"name":56,"role":23,"phone":57,"phoneExt":11,"email":58},"Olivier MANSIER, DOCTOR","+335 57 65 64 78","olivier.mansier@u-bordeaux.fr",{"facility":60,"status":33,"city":61,"state":11,"zip":62,"country":35,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Chu Brest","Brest","29200",{"type":37,"coordinates":64},[65,66],-4.48628,48.39029,{"lat":66,"lon":65},[69],{"name":70,"role":23,"phone":71,"phoneExt":11,"email":72},"ERIC LIPPERT, PROFESSOR","+332 98 34 70 33","eric.lippert@chu-brest.fr",{"facility":74,"status":33,"city":75,"state":11,"zip":76,"country":35,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Ch Cholet","Cholet","49300",{"type":37,"coordinates":78},[79,80],-0.87974,47.05893,{"lat":80,"lon":79},[83],{"name":84,"role":23,"phone":85,"phoneExt":11,"email":86},"CHARLES BESCOND, DOCTOR","+332 41 49 68 07","alain.zannetti@ch-cholet.fr",{"facility":88,"status":33,"city":89,"state":11,"zip":90,"country":35,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"Ch Le Mans","Le Mans","72037",{"type":37,"coordinates":92},[93,94],0.20251,48.0021,{"lat":94,"lon":93},[97],{"name":98,"role":23,"phone":99,"phoneExt":11,"email":100},"KAMEL LARIBI, DOCTOR","+332 43 43 43 60","klaribi@ch-lemans.fr",{"facility":102,"status":33,"city":103,"state":11,"zip":104,"country":35,"cosmosGeoPoint":105,"geoPoint":109,"contacts":110},"Ch Morlaix","Morlaix","29672",{"type":37,"coordinates":106},[107,108],-3.82792,48.57784,{"lat":108,"lon":107},[111],{"name":112,"role":23,"phone":113,"phoneExt":11,"email":114},"CHRISTOPHE NICOL, DOCTOR","+332 98 62 60 38","CNicol@ch-morlaix.fr",{"facility":116,"status":33,"city":117,"state":11,"zip":118,"country":35,"cosmosGeoPoint":119,"geoPoint":123,"contacts":124},"AP-HP Henri Mondor","Paris","94010",{"type":37,"coordinates":120},[121,122],2.3488,48.85341,{"lat":122,"lon":121},[125],{"name":126,"role":23,"phone":127,"phoneExt":11,"email":128},"Lydia ROY, DOCTOR","+331 49 81 20 57","lydia.roy@aphp.fr",{"facility":130,"status":33,"city":131,"state":11,"zip":132,"country":35,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"Chu Poitiers","Poitiers","86021",{"type":37,"coordinates":134},[135,136],0.34348,46.58261,{"lat":136,"lon":135},[139],{"name":140,"role":23,"phone":141,"phoneExt":11,"email":142},"Jose Miguel TORREGROSA-DIAZ, DOCTOR","+335 49 44 44 44","jose-miguel.torregrosa-diaz@inserm.eu",{"facility":144,"status":33,"city":145,"state":11,"zip":146,"country":35,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"Ch Quimper","Quimper","29107",{"type":37,"coordinates":148},[149,150],-4.09795,47.99597,{"lat":150,"lon":149},[153],{"name":154,"role":23,"phone":155,"phoneExt":11,"email":156},"Lenaig LE CLECH, DOCTOR","+332 98 52 61 50","l.leclech@ch-cornouaille.fr",{"facility":158,"status":33,"city":159,"state":11,"zip":160,"country":35,"cosmosGeoPoint":161,"geoPoint":165,"contacts":166},"Chu Tours","Tours","37000",{"type":37,"coordinates":162},[163,164],0.70398,47.39484,{"lat":164,"lon":163},[167],{"name":168,"role":23,"phone":169,"phoneExt":11,"email":170},"Olivier HERAULT, PROFESSOR","+332 47 47 47 21","olivier.herault@univ-tours.fr",{"type":172,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[174],{"name":175,"class":176},"Ligue contre le cancer, France","OTHER","100434814",false,"NCT04942080","Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)","CALRSUIVI","Inclusion Criteria:\n\n* adults (age ≥18 years),\n* affiliated to the national social security system,\n* with CALR mutated myeloproliferative neoplasm diagnosed between 2006 - 2020,\n* for which at least one sample is available at the time of diagnosis or before cytoreductive treatment,\n* who signed the consent to participate in the study,\n* included, or consenting to be included, in the national clinical-biological database of France Intergroupe Syndrome Myéloprolifératifs (FIM).\n\nExclusion Criteria:\n\n* patient with another active hematological disease or cancer at the time of diagnosis,\n* person subject to legal protection scheme or incapable of giving consent.","ALL","18 Years",{"count":186,"type":187},260,"ESTIMATED","INTERVENTIONAL",[190],"NA","Prospective study to evaluate the relevance of CALR allele burden monitoring as a molecular marker of disease progression.",[193,194,195,196],"Myeloproliferative Neoplasm","Essential Thrombocythemia","Primary Myelofibrosis, Prefibrotic Stage","Primary Myelofibrosis, Fibrotic Stage",[198,193,194,199,200],"CALR","Primary Myelofibrosis","Thrombocytosis","2026-03-05",{"date":203,"type":204},"2026-03-06","ACTUAL",{"date":206,"type":204},"2021-10-28",{"date":208,"type":187},"2030-04-28",{"name":5,"class":6},10]